Showing 63,501 - 63,520 results of 101,702 for search '(( 2 step decrease ) OR ( 5 ((wt decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.59s Refine Results
  1. 63501

    Viral replicative advantages and pathological consequences related to STAT3-altered function. by Armando Andres Roca Suarez (4967134)

    Published 2018
    “…ANGPTL4, angiopoietin-like protein 4; APR, acute phase response; BIRC5, baculoviral IAP repeat-containing protein 5; CCL5, C-C motif chemokine ligand 5; DCs, dendritic cells; DC-SIGN, dendritic cell-specific ICAM-3-grabbing non-integrin 1; EBV, Epstein–Barr virus; FOS, proto-oncogene c-Fos; HCC, hepatocellular carcinoma; HCMV, human cytomegalovirus; HCV, hepatitis C virus; HEV, hepatitis E virus; HSCs, hepatic stellate cells; IAV, influenza A virus; IDO1, indoleamine 2,3-dioxygenase 1; IL-10, interleukin 10; ISG, interferon-stimulated gene; JUN, proto-oncogene c-Jun; KSHV, Kaposi’s sarcoma-associated herpesvirus; MCL1, induced myeloid leukemia cell differentiation protein Mcl-1; MDSCs, myeloid-derived suppressor cells; MT, microtubule; MUC1, mucin 1 cell surface associated; MuV, mumps virus; NPC, nasopharyngeal carcinoma; NR4A2, nuclear receptor subfamily 4 group A member 2; PCBP2, poly(rC)-binding protein 2; PD-L1, programmed cell death 1 ligand 1; RTA, R transactivator; RVFV, Rift Valley fever virus; STAT3, signal transducer and activator of transcription 3; TGF-β, transforming growth factor beta; T<sub>reg</sub>, regulatory CD4<sup>+</sup> T cell; VZV, varicella-zoster virus.…”
  2. 63502

    Image_3_Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.jpg by Robert Ossendorff (16653054)

    Published 2023
    “…These findings were supported by a decrease in matrix differentiation (COL-II). …”
  3. 63503

    Image_4_Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.jpg by Robert Ossendorff (16653054)

    Published 2023
    “…These findings were supported by a decrease in matrix differentiation (COL-II). …”
  4. 63504

    Image_2_Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.jpg by Robert Ossendorff (16653054)

    Published 2023
    “…These findings were supported by a decrease in matrix differentiation (COL-II). …”
  5. 63505

    Week 6 & 7 Experimental Design: Impact of the Anthropocene on bug abundance by Naduni Kurukulasooriya (795949)

    Published 2015
    “…Every 5 meters was considered a new group, the first 5 meters was Group 1 and the last was Group 6. …”
  6. 63506
  7. 63507
  8. 63508

    Table_2_Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.DOCX by Nan Lin (26755)

    Published 2020
    “…Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). …”
  9. 63509

    Table_1_Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.DOCX by Nan Lin (26755)

    Published 2020
    “…Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). …”
  10. 63510

    Table_2_Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.DOCX by Nan Lin (26755)

    Published 2020
    “…Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). …”
  11. 63511

    Table_1_Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.DOCX by Nan Lin (26755)

    Published 2020
    “…Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). …”
  12. 63512

    Temporal Trend in Young-Onset Type 2 Diabetes - the Macrovascular and Mortality Risk: Study of UK Primary Care Electronic Medical Records by Digsu N. Koye (8881108)

    Published 2020
    “…The incidence rates of ASCVD and ACM declined in people aged ≥50 years, but did not decrease in people <50 years. Compared to people aged ≥50 years, those aged 18-39 years at diagnosis had higher obesity (71% obese), higher HbA1c (8.6%), 71% had high LDL-C, while only 18% were on cardio-protective therapy. …”
  13. 63513

    Population sorting II. by Xavier Manière (230820)

    Published 2011
    “…<p>(A) We numerically computed the histograms of the distance traveled by a fictitious population of 1000 worms assuming a Gaussian velocity distribution for each worm with an average parallel velocity given by v<sub>0</sub>(1+gnoise(µ)) and a standard deviation of 50 µm/s. …”
  14. 63514

    Tobacco control in the Eastern Mediterranean region: implementation progress and persisting challenges by Abu-Rmeileh, Niveen M E

    Published 2022
    “…Tobacco use is the leading cause of preventable mortality worldwide, projected to claim 1 billion lives in the twenty-first century.1 Tobacco prevalence rates are expected to decrease across all the WHO regions by 2025 as a result of tobacco control efforts. …”
    Get full text
    Get full text
  15. 63515

    Concomitant experimental coinfection by Plasmodium berghei NK65-NY and Ascaris suum downregulates the Ascaris-specific immune response and potentiates Ascaris-associated lung patho... by Flaviane Vieira-Santos (8357704)

    Published 2020
    “…The concentrations of interleukin (IL)-1β, IL-12/IL-23p40, IL-6, IL-4, IL-33, IL-13, IL-5, IL-10, IL-17A, IFN-γ, TNF-α and TGF-β were assayed by sandwich ELISA. …”
  16. 63516

    Data_Sheet_4_Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2.PDF by Martin Michaelis (23843)

    Published 2019
    “…Omeprazole 80 μg/mL caused a 10.8-fold (Vero cells) and 47.7-fold (HaCaT cells) decrease of the acyclovir concentrations that reduced HSV-1-induced CPE formation by 50% (IC<sub>50</sub>). …”
  17. 63517

    Effect of De-intensifying Diabetes Medications on Negative Events in Older Veteran Nursing Home Residents by Joshua D. Niznik (12480320)

    Published 2022
    “…Diabetes treatment de-intensification (dose decrease or discontinuation of a non-insulin agent or stopping insulin sustained ≥7 days) was identified within 30 days following HbA1c measurement. …”
  18. 63518

    Untargeted Urinary Proteomics Uncovers Nephroprotective and Systemic Adaptations after Obesity Surgery-Induced Weight Loss by Pedro R. Pereira (6016460)

    Published 2025
    “…A decrease in inflammation protein markers (α-1-acid glycoproteins), alongside an increase in proteins associated with immune modulation and oxidative stress protection (dipeptidase 1, heat shock cognate 71 kDa protein) were observed. …”
  19. 63519

    Data_Sheet_2_Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2.PDF by Martin Michaelis (23843)

    Published 2019
    “…Omeprazole 80 μg/mL caused a 10.8-fold (Vero cells) and 47.7-fold (HaCaT cells) decrease of the acyclovir concentrations that reduced HSV-1-induced CPE formation by 50% (IC<sub>50</sub>). …”
  20. 63520

    Data_Sheet_1_Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2.PDF by Martin Michaelis (23843)

    Published 2019
    “…Omeprazole 80 μg/mL caused a 10.8-fold (Vero cells) and 47.7-fold (HaCaT cells) decrease of the acyclovir concentrations that reduced HSV-1-induced CPE formation by 50% (IC<sub>50</sub>). …”